92 related articles for article (PubMed ID: 2241961)
21. Modulation of human platelet protein kinase C by endotoxic lipid A.
Grabarek J; Timmons S; Hawiger J
J Clin Invest; 1988 Sep; 82(3):964-71. PubMed ID: 3047171
[TBL] [Abstract][Full Text] [Related]
22. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
[TBL] [Abstract][Full Text] [Related]
24. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.
Martinson EA; Scheible S; Greinacher A; Presek P
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):623-8. PubMed ID: 7544577
[TBL] [Abstract][Full Text] [Related]
25. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide.
Edsall LC; Van Brocklyn JR; Cuvillier O; Kleuser B; Spiegel S
Biochemistry; 1998 Sep; 37(37):12892-8. PubMed ID: 9737868
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
[TBL] [Abstract][Full Text] [Related]
27. Activation of phospholipase D in human platelets by collagen and thrombin and its relationship to platelet aggregation.
Chiang TM
Biochim Biophys Acta; 1994 Oct; 1224(1):147-55. PubMed ID: 7948037
[TBL] [Abstract][Full Text] [Related]
28. Collagen-induced platelet activation mainly involves the protein kinase C pathway.
Karniguian A; Grelac F; Levy-Toledano S; Legrand YJ; Rendu F
Biochem J; 1990 Jun; 268(2):325-31. PubMed ID: 2163606
[TBL] [Abstract][Full Text] [Related]
29. Endotoxic lipid A interaction with human platelets. Structure-function analysis of lipid A homologs obtained from Salmonella minnesota Re595 lipopolysaccharide.
Grabarek J; Her GR; Reinhold VN; Hawiger J
J Biol Chem; 1990 May; 265(14):8117-21. PubMed ID: 2335520
[TBL] [Abstract][Full Text] [Related]
30. Selectivity of sphingosine-induced apoptosis. Lack of activity of DL-erythyro-dihydrosphingosine.
Sakakura C; Sweeney EA; Shirahama T; Hagiwara A; Yamaguchi T; Takahashi T; Hakomori S; Igarashi Y
Biochem Biophys Res Commun; 1998 May; 246(3):827-30. PubMed ID: 9618297
[TBL] [Abstract][Full Text] [Related]
31. The intracellular action of sphingosine 1-phosphate in GPVI-mediated Ca2+ mobilization in platelets.
Ohmori T; Yatomi Y; Osada M; Ozaki Y
Thromb Res; 2005; 115(5):409-15. PubMed ID: 15733975
[TBL] [Abstract][Full Text] [Related]
32. Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice.
Endo K; Igarashi Y; Nisar M; Zhou QH; Hakomori S
Cancer Res; 1991 Mar; 51(6):1613-8. PubMed ID: 1998952
[TBL] [Abstract][Full Text] [Related]
33. Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
Yoshimitsu Y; Oishi S; Miyagaki J; Inuki S; Ohno H; Fujii N
Bioorg Med Chem; 2011 Sep; 19(18):5402-8. PubMed ID: 21868240
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine enhances phosphatidylinositol 4-kinase activity in rabbit platelets.
Hashizume T; Nakao M; Sato T
J Biochem; 1996 Jul; 120(1):61-5. PubMed ID: 8864845
[TBL] [Abstract][Full Text] [Related]
35. Ni2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets.
Azula FJ; Alonso R; Marino A; Trueba M; Macarulla JM
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1681-8. PubMed ID: 8279529
[TBL] [Abstract][Full Text] [Related]
36. Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism.
Siess W; Lapetina EG
Biochem J; 1989 Oct; 263(2):377-85. PubMed ID: 2574568
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses.
Murphy CT; Westwick J
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):159-64. PubMed ID: 1567363
[TBL] [Abstract][Full Text] [Related]
38. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
39. Suppression by wortmannin of platelet responses to stimuli due to inhibition of pleckstrin phosphorylation.
Yatomi Y; Hazeki O; Kume S; Ui M
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):745-51. PubMed ID: 1497612
[TBL] [Abstract][Full Text] [Related]
40. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
